Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Cancers|September 28, 2023
A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic BiopsiesJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.Urologic Oncology|May 27, 2023
Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/ml and an abnormal digital rectal examination?Juan Morote, Natàlia Picola, Nahuel Paesano, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 6, 2024
Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with trans-perineal prostate biopsiesJuan Morote, Nahuel Paesano, Natàlia Picola, et al.Biomolecules|February 24, 2024
Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer DetectionJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.Journal of Medicinal Chemistry|January 15, 2020
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion ChannelDongwei Kang, F Xavier Ruiz, Da Feng, et al.Diagnostics (Basel, Switzerland)|February 13, 2025
Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired-Matched StudyNahuel Paesano, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.Life (Basel, Switzerland)|November 27, 2024
The Role of Digital Rectal Examination for Early Detection of Significant Prostate Cancer in the Era of Magnetic Resonance ImagingJuan Morote, Nahuel Paesano, Natàlia Picola, et al.Journal of Virology|February 12, 2025
The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in miceEvan P Williams, Yi Xue, Peter Vogel, et al.The Journal of Urology|August 27, 2025
A semen panel signature comprising sTWEAK Cytokine levels and expression of exomiR-221-3p and exomiR-222-3p for assessing prostate cancer prognosis, diagnostic utility, and detection of upgrading during active surveillanceMarta Alves-Santiago, Antonio Altuna-Coy, Pablo López-Ribelles, et al.Cancers|April 14, 2025
Developing a Predictive Model for Significant Prostate Cancer Detection in Prostatic Biopsies from Seven Clinical Variables: Is Machine Learning Superior to Logistic Regression?Juan Morote, Berta Miró, Patricia Hernando, et al.Pageof 7